Cargando…

Loss of Sympathetic Nerves in Spleens from Patients with End Stage Sepsis

The spleen is an important site for central regulation of immune function by noradrenergic sympathetic nerves, but little is known about this major region of neuroimmune communication in humans. Experimental studies using animal models have established that sympathetic innervation of the spleen is e...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoover, Donald B., Brown, Thomas Christopher, Miller, Madeleine K., Schweitzer, John B., Williams, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723638/
https://www.ncbi.nlm.nih.gov/pubmed/29270174
http://dx.doi.org/10.3389/fimmu.2017.01712
_version_ 1783285246264868864
author Hoover, Donald B.
Brown, Thomas Christopher
Miller, Madeleine K.
Schweitzer, John B.
Williams, David L.
author_facet Hoover, Donald B.
Brown, Thomas Christopher
Miller, Madeleine K.
Schweitzer, John B.
Williams, David L.
author_sort Hoover, Donald B.
collection PubMed
description The spleen is an important site for central regulation of immune function by noradrenergic sympathetic nerves, but little is known about this major region of neuroimmune communication in humans. Experimental studies using animal models have established that sympathetic innervation of the spleen is essential for cholinergic anti-inflammatory responses evoked by vagal nerve stimulation, and clinical studies are evaluating this approach for treating inflammatory diseases. Most data on sympathetic nerves in spleen derive from rodent studies, and this work has established that remodeling of sympathetic innervation can occur during inflammation. However, little is known about the effects of sepsis on spleen innervation. Our primary goals were to (i) localize noradrenergic nerves in human spleen by immunohistochemistry for tyrosine hydroxylase (TH), a specific noradrenergic marker, (ii) determine if nerves occur in close apposition to leukocytes, and (iii) determine if splenic sympathetic innervation is altered in patients who died from end stage sepsis. Staining for vesicular acetylcholine transporter (VAChT) was done to screen for cholinergic nerves. Archived paraffin tissue blocks were used. Control samples were obtained from trauma patients or patients who died after hemorrhagic stroke. TH + nerves were associated with arteries and arterioles in all control spleens, occurring in bundles or as nerve fibers. Individual TH + nerve fibers entered the perivascular region where some appeared in close apposition to leukocytes. In marked contrast, spleens from half of the septic patients lacked TH + nerves fibers and the average abundance of TH + nerves for the septic group was only 16% of that for the control group (control: 0.272 ± 0.060% area, n = 6; sepsis: 0.043 ± 0.026% area, n = 8; P < 0.005). All spleens lacked cholinergic innervation. Our results provide definitive evidence for the distribution of noradrenergic nerves in normal human spleen and the first evidence for direct sympathetic innervation of leukocytes in human spleen. We also provide the first evidence for marked loss of noradrenergic nerves in patients who died from sepsis. Such nerve loss could impair neuroimmunomodulation and may not be limited to the spleen.
format Online
Article
Text
id pubmed-5723638
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-57236382017-12-21 Loss of Sympathetic Nerves in Spleens from Patients with End Stage Sepsis Hoover, Donald B. Brown, Thomas Christopher Miller, Madeleine K. Schweitzer, John B. Williams, David L. Front Immunol Immunology The spleen is an important site for central regulation of immune function by noradrenergic sympathetic nerves, but little is known about this major region of neuroimmune communication in humans. Experimental studies using animal models have established that sympathetic innervation of the spleen is essential for cholinergic anti-inflammatory responses evoked by vagal nerve stimulation, and clinical studies are evaluating this approach for treating inflammatory diseases. Most data on sympathetic nerves in spleen derive from rodent studies, and this work has established that remodeling of sympathetic innervation can occur during inflammation. However, little is known about the effects of sepsis on spleen innervation. Our primary goals were to (i) localize noradrenergic nerves in human spleen by immunohistochemistry for tyrosine hydroxylase (TH), a specific noradrenergic marker, (ii) determine if nerves occur in close apposition to leukocytes, and (iii) determine if splenic sympathetic innervation is altered in patients who died from end stage sepsis. Staining for vesicular acetylcholine transporter (VAChT) was done to screen for cholinergic nerves. Archived paraffin tissue blocks were used. Control samples were obtained from trauma patients or patients who died after hemorrhagic stroke. TH + nerves were associated with arteries and arterioles in all control spleens, occurring in bundles or as nerve fibers. Individual TH + nerve fibers entered the perivascular region where some appeared in close apposition to leukocytes. In marked contrast, spleens from half of the septic patients lacked TH + nerves fibers and the average abundance of TH + nerves for the septic group was only 16% of that for the control group (control: 0.272 ± 0.060% area, n = 6; sepsis: 0.043 ± 0.026% area, n = 8; P < 0.005). All spleens lacked cholinergic innervation. Our results provide definitive evidence for the distribution of noradrenergic nerves in normal human spleen and the first evidence for direct sympathetic innervation of leukocytes in human spleen. We also provide the first evidence for marked loss of noradrenergic nerves in patients who died from sepsis. Such nerve loss could impair neuroimmunomodulation and may not be limited to the spleen. Frontiers Media S.A. 2017-12-06 /pmc/articles/PMC5723638/ /pubmed/29270174 http://dx.doi.org/10.3389/fimmu.2017.01712 Text en Copyright © 2017 Hoover, Brown, Miller, Schweitzer and Williams. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Hoover, Donald B.
Brown, Thomas Christopher
Miller, Madeleine K.
Schweitzer, John B.
Williams, David L.
Loss of Sympathetic Nerves in Spleens from Patients with End Stage Sepsis
title Loss of Sympathetic Nerves in Spleens from Patients with End Stage Sepsis
title_full Loss of Sympathetic Nerves in Spleens from Patients with End Stage Sepsis
title_fullStr Loss of Sympathetic Nerves in Spleens from Patients with End Stage Sepsis
title_full_unstemmed Loss of Sympathetic Nerves in Spleens from Patients with End Stage Sepsis
title_short Loss of Sympathetic Nerves in Spleens from Patients with End Stage Sepsis
title_sort loss of sympathetic nerves in spleens from patients with end stage sepsis
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723638/
https://www.ncbi.nlm.nih.gov/pubmed/29270174
http://dx.doi.org/10.3389/fimmu.2017.01712
work_keys_str_mv AT hooverdonaldb lossofsympatheticnervesinspleensfrompatientswithendstagesepsis
AT brownthomaschristopher lossofsympatheticnervesinspleensfrompatientswithendstagesepsis
AT millermadeleinek lossofsympatheticnervesinspleensfrompatientswithendstagesepsis
AT schweitzerjohnb lossofsympatheticnervesinspleensfrompatientswithendstagesepsis
AT williamsdavidl lossofsympatheticnervesinspleensfrompatientswithendstagesepsis